Both in Biotechnology
Bio-Techne vs Neurocrine Biosciences
Over the past year TECH returned +16.1% and NBIX returned +2.0%; their daily moves had a correlation of -0.00.
TECH +16.1% NBIX +2.0%Growth of $1, one year, split-adjusted
| Metric | TECH | NBIX |
|---|---|---|
| Price | $72.66 | $146.10 |
| Market cap | $11.41B | $14.85B |
| Today | −0.07% | −0.19% |
| 1 month | +0.4% | +3.8% |
| 6 months | +32.1% | +10.9% |
| Year to date | +23.6% | +3.0% |
| 1 year | +17.2% | +5.9% |
| Revenue growth (YoY) | +1.3% | +39.5% |
| Gross margin | 65.8% | 97.6% |
| Net margin | 17.0% | 15.1% |
| P/E (TTM) | 62.7× | 21.1× |
| Price / sales | 9.4× | 4.4× |
| Net cash | $64.7M | $389.8M |
| Dividend yield | 0.44% | — |
| Volatility (60d) | 2.5% | 26.3% |
| Short % of float | 4.9% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).